News
In a press release announcing the move, Novo Nordisk cited market challenges and its declining share price in a press release ...
The CEO of Danish pharmaceutical giant Novo Nordisk, known for its blockbuster weight-loss drug Ozempic, will step down, the ...
(Reuters) -As Denmark's Novo Nordisk shops for its next CEO to replace Lars Fruergaard Jorgensen, it should look across the ...
21hon MSN
Investors may get a second bite at the apple, and a second chance to buy this GLP-1 drug leader at a discount price.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results